Skip to content

H.R. 4525 · 119th Congress (2025–2027)

Right to FDA-Approved Medicines Act

This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).

Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993.

The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.

Show official title

To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 4525’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Deborah K. Ross (D-NC-2)
Cosponsors
29 cosponsors

4 original · 25 later

29 D

  1. Rep. Kathy Castor (D-FL-14)· Original · Jul 17, 2025
  2. Rep. Lizzie Fletcher (D-TX-7)· Original · Jul 17, 2025
  3. Rep. Kim Schrier (D-WA-8)· Original · Jul 17, 2025
  4. Rep. Lori Trahan (D-MA-3)· Original · Jul 17, 2025
  5. Rep. Bonnie Watson Coleman (D-NJ-12)· Later · Jul 21, 2025
  6. Rep. Steve Cohen (D-TN-9)· Later · Jul 29, 2025
  7. Rep. Jennifer L. McClellan (D-VA-4)· Later · Jul 29, 2025
  8. Rep. Nikema Williams (D-GA-5)· Later · Jul 29, 2025
  9. Rep. Marilyn Strickland (D-WA-10)· Later · Aug 5, 2025
  10. Rep. Yvette D. Clarke (D-NY-9)· Later · Aug 12, 2025
  11. Rep. Suzan K. DelBene (D-WA-1)· Later · Aug 12, 2025
  12. Rep. Mary Gay Scanlon (D-PA-5)· Later · Aug 12, 2025
  13. Rep. Veronica Escobar (D-TX-16)· Later · Jan 20, 2026
  14. Rep. Timothy M. Kennedy (D-NY-26)· Later · Jan 20, 2026
  15. Rep. Joyce Beatty (D-OH-3)· Later · Jan 21, 2026
  16. Rep. Sarah Elfreth (D-MD-3)· Later · Jan 21, 2026
  17. Rep. Grace Meng (D-NY-6)· Later · Jan 22, 2026
  18. Rep. Dina Titus (D-NV-1)· Later · Jan 22, 2026
  19. Rep. Ted Lieu (D-CA-36)· Later · Jan 30, 2026
  20. Rep. Scott H. Peters (D-CA-50)· Later · Jan 30, 2026
  21. Rep. Marc A. Veasey (D-TX-33)· Later · Jan 30, 2026
  22. Rep. Lois Frankel (D-FL-22)· Later · Feb 11, 2026
  23. Rep. Julie Johnson (D-TX-32)· Later · Feb 11, 2026
  24. Rep. Mark DeSaulnier (D-CA-10)· Later · Mar 19, 2026
  25. Rep. Jahana Hayes (D-CT-5)· Later · Mar 19, 2026
  26. Rep. April McClain Delaney (D-MD-6)· Later · Apr 27, 2026
  27. Rep. Angie Craig (D-MN-2)· Later · Apr 30, 2026
  28. Rep. Wesley Bell (D-MO-1)· Later · Jun 24, 2026
  29. Rep. Christopher R. Deluzio (D-PA-17)· Later · Jul 9, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jul 17, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Right to FDA-Approved Medicines Act

    Display title, Short title · Introduced in House

  2. To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines.

    Official title · Introduced in House